FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:LEMD3-KCNC2

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: LEMD3-KCNC2
FusionPDB ID: 44432
FusionGDB2.0 ID: 44432
HgeneTgene
Gene symbol

LEMD3

KCNC2

Gene ID

23592

3747

Gene nameLEM domain containing 3potassium voltage-gated channel subfamily C member 2
SynonymsMAN1KV3.2
Cytomap

12q14.3

12q21.1

Type of geneprotein-codingprotein-coding
Descriptioninner nuclear membrane protein Man1LEM domain-containing protein 3LEMD3/MKX fusionintegral inner nuclear membrane proteinpotassium voltage-gated channel subfamily C member 2potassium channel, voltage gated Shaw related subfamily C, member 2potassium voltage-gated channel, Shaw-related subfamily, member 2shaw-like potassium channelvoltage-gated potassium channel Kv3.2
Modification date2020031320200313
UniProtAcc

Q9Y2U8

Main function of 5'-partner protein: FUNCTION: Can function as a specific repressor of TGF-beta, activin, and BMP signaling through its interaction with the R-SMAD proteins. Antagonizes TGF-beta-induced cell proliferation arrest. {ECO:0000269|PubMed:15601644, ECO:0000269|PubMed:15647271}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000308330, ENST00000541171, 
ENST00000548243, ENST00000298972, 
ENST00000341669, ENST00000350228, 
ENST00000393288, ENST00000540018, 
ENST00000548513, ENST00000549446, 
ENST00000550433, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score13 X 8 X 6=62415 X 5 X 6=450
# samples 1416
** MAII scorelog2(14/624*10)=-2.15611920191728
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(16/450*10)=-1.49185309632967
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: LEMD3 [Title/Abstract] AND KCNC2 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: LEMD3 [Title/Abstract] AND KCNC2 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)LEMD3(65612399)-KCNC2(75445097), # samples:2
Anticipated loss of major functional domain due to fusion event.LEMD3-KCNC2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
LEMD3-KCNC2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
LEMD3-KCNC2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
LEMD3-KCNC2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneLEMD3

GO:0030512

negative regulation of transforming growth factor beta receptor signaling pathway

15647271

HgeneLEMD3

GO:0030514

negative regulation of BMP signaling pathway

15647271

HgeneLEMD3

GO:0032926

negative regulation of activin receptor signaling pathway

15647271



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:65612399/chr12:75445097)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across LEMD3 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across KCNC2 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000308330LEMD3chr1265612399+ENST00000550433KCNC2chr1275445097-39441721262923965
ENST00000308330LEMD3chr1265612399+ENST00000548513KCNC2chr1275445097-40391721262875949
ENST00000308330LEMD3chr1265612399+ENST00000549446KCNC2chr1275445097-59781721262950974
ENST00000308330LEMD3chr1265612399+ENST00000298972KCNC2chr1275445097-40001721262875949
ENST00000308330LEMD3chr1265612399+ENST00000341669KCNC2chr1275445097-39051721262923965
ENST00000308330LEMD3chr1265612399+ENST00000350228KCNC2chr1275445097-38341721262710894
ENST00000308330LEMD3chr1265612399+ENST00000540018KCNC2chr1275445097-29301721262785919
ENST00000308330LEMD3chr1265612399+ENST00000393288KCNC2chr1275445097-32711721262890954

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000308330ENST00000550433LEMD3chr1265612399+KCNC2chr1275445097-0.0003357840.9996642
ENST00000308330ENST00000548513LEMD3chr1265612399+KCNC2chr1275445097-0.0003314910.9996685
ENST00000308330ENST00000549446LEMD3chr1265612399+KCNC2chr1275445097-0.0001885910.9998115
ENST00000308330ENST00000298972LEMD3chr1265612399+KCNC2chr1275445097-0.0003449130.9996551
ENST00000308330ENST00000341669LEMD3chr1265612399+KCNC2chr1275445097-0.0003472920.99965274
ENST00000308330ENST00000350228LEMD3chr1265612399+KCNC2chr1275445097-0.0005135960.9994863
ENST00000308330ENST00000540018LEMD3chr1265612399+KCNC2chr1275445097-0.0010437650.9989562
ENST00000308330ENST00000393288LEMD3chr1265612399+KCNC2chr1275445097-0.0004699370.9995301

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for LEMD3-KCNC2

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
LEMD3chr1265612399KCNC2chr12754450971721563SQRTLSVQEAAAYLKFIAFASLFFIL

Top

Potential FusionNeoAntigen Information of LEMD3-KCNC2 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
LEMD3-KCNC2_65612399_75445097.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B44:03QEAAAYLKF0.99920.9433716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:02AAYLKFIAF0.99720.91791019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:25AAYLKFIAF0.99720.90761019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B18:01QEAAAYLKF0.99520.7842716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:03AAYLKFIAF0.99510.74011019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:17AAYLKFIAF0.9940.88911019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:01AAYLKFIAF0.99370.85631019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B13:01QEAAAYLKF0.99320.9634716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:16AAYLKFIAF0.99280.85041019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B08:01AAYLKFIAF0.98360.5571019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B08:09AAYLKFIAF0.96370.64751019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B14:01AAYLKFIAF0.92610.73461019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B14:02AAYLKFIAF0.92610.73461019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-A32:13AAYLKFIAF0.91470.89021019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B52:01AAYLKFIAF0.77890.97391019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B44:03SVQEAAAYLKF0.8980.9103516
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:21AAYLKFIAF0.99730.88321019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C03:08AAYLKFIAF0.99610.82521019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:07AAYLKFIAF0.99520.60431019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C12:16AAYLKFIAF0.99060.95251019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C03:19AAYLKFIAF0.98920.98471019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:05AAYLKFIAF0.98710.78721019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C15:04AAYLKFIAF0.98310.86221019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C07:05AAYLKFIAF0.9810.92931019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B42:02AAYLKFIAF0.98090.55451019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C12:12AAYLKFIAF0.98040.92771019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C03:07AAYLKFIAF0.95590.97691019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C07:46AAYLKFIAF0.95280.86521019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C15:06AAYLKFIAF0.94660.91211019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:04AAYLKFIAF0.93880.88591019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C03:14AAYLKFIAF0.93320.95731019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C04:06AAYLKFIAF0.88450.84881019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C12:04AAYLKFIAF0.8250.98971019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C06:03AAYLKFIAF0.82480.9911019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C08:13AAYLKFIAF0.71890.95721019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C08:04AAYLKFIAF0.71890.95721019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B51:07AAYLKFIAF0.70850.95321019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B14:03AAYLKFIAF0.66190.68911019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C02:06AAYLKFIAF0.5350.96261019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C08:03AAYLKFIAF0.4110.98551019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C14:02AYLKFIAF0.95840.93681119
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C14:03AYLKFIAF0.95840.93681119
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B44:07QEAAAYLKF0.99920.9433716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B44:26QEAAAYLKF0.99920.9433716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B44:13QEAAAYLKF0.99920.9433716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C03:02AAYLKFIAF0.99810.9541019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B18:04QEAAAYLKF0.99720.7986716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:39AAYLKFIAF0.99710.82561019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B18:07QEAAAYLKF0.99690.7335716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C03:67AAYLKFIAF0.99650.97271019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C03:03AAYLKFIAF0.99640.98251019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C03:04AAYLKFIAF0.99640.98251019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B35:11AAYLKFIAF0.99630.88431019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B18:05QEAAAYLKF0.99520.7842716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:08AAYLKFIAF0.99480.79571019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:11AAYLKFIAF0.99480.80011019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:35AAYLKFIAF0.99470.82641019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B18:08QEAAAYLKF0.99450.7351716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B58:06AAYLKFIAF0.99440.88011019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B18:06QEAAAYLKF0.99440.7928716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C16:04AAYLKFIAF0.99440.97331019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:34AAYLKFIAF0.99370.85631019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:33AAYLKFIAF0.99370.85631019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:125AAYLKFIAF0.99370.85631019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:27AAYLKFIAF0.99330.88071019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:135AAYLKFIAF0.99320.86721019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B35:30AAYLKFIAF0.99280.68671019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B35:17AAYLKFIAF0.99280.68671019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B35:43AAYLKFIAF0.99260.79921019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B18:11QEAAAYLKF0.9920.8336716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:13AAYLKFIAF0.99160.7521019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B18:03QEAAAYLKF0.99130.7663716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B40:04QEAAAYLKF0.99020.7548716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:50AAYLKFIAF0.99010.88791019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C03:05AAYLKFIAF0.98980.87561019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:24AAYLKFIAF0.98960.92631019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:53AAYLKFIAF0.98860.82111019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:20AAYLKFIAF0.98820.85921019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C03:17AAYLKFIAF0.98720.95081019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C07:17AAYLKFIAF0.98690.95061019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-A32:01AAYLKFIAF0.98630.94761019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B35:28AAYLKFIAF0.98620.8641019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B08:18AAYLKFIAF0.98360.5571019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C15:09AAYLKFIAF0.98310.86221019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:54AAYLKFIAF0.98040.79021019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C16:01AAYLKFIAF0.97960.96751019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C12:03AAYLKFIAF0.9790.96931019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B35:23AAYLKFIAF0.97790.85031019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B35:20AAYLKFIAF0.97730.8691019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B48:02AAYLKFIAF0.97490.83331019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:12AAYLKFIAF0.95820.70531019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B35:24AAYLKFIAF0.95650.82411019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C12:02AAYLKFIAF0.95340.95521019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B35:13AAYLKFIAF0.91560.83191019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C15:02AAYLKFIAF0.86250.8581019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B08:12AAYLKFIAF0.85250.73191019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C03:06AAYLKFIAF0.78690.98341019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C16:02AAYLKFIAF0.78390.98461019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B35:20QEAAAYLKF0.7020.9224716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B35:28QEAAAYLKF0.68540.9197716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B18:04AAYLKFIAF0.60490.84191019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C02:10AAYLKFIAF0.57390.971019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C02:02AAYLKFIAF0.57390.971019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B07:13AAYLKFIAF0.5050.63331019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B18:07AAYLKFIAF0.46290.73521019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B15:53QEAAAYLKF0.44670.8177716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B18:03AAYLKFIAF0.43850.80041019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C08:01AAYLKFIAF0.4110.98551019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B18:08AAYLKFIAF0.4040.77951019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B48:02QEAAAYLKF0.39730.8978716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B41:03QEAAAYLKF0.39540.7281716
LEMD3-KCNC2chr1265612399chr12754450971721HLA-C17:01AAYLKFIAF0.11350.92271019
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B44:07SVQEAAAYLKF0.8980.9103516
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B44:13SVQEAAAYLKF0.8980.9103516
LEMD3-KCNC2chr1265612399chr12754450971721HLA-B44:26SVQEAAAYLKF0.8980.9103516

Top

Potential FusionNeoAntigen Information of LEMD3-KCNC2 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
LEMD3-KCNC2_65612399_75445097.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1201SQRTLSVQEAAAYLK015
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1201QRTLSVQEAAAYLKF116
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1203SQRTLSVQEAAAYLK015
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1203QRTLSVQEAAAYLKF116
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1205SQRTLSVQEAAAYLK015
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1205QRTLSVQEAAAYLKF116
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1206SQRTLSVQEAAAYLK015
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1206QRTLSVQEAAAYLKF116
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1207SQRTLSVQEAAAYLK015
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1207QRTLSVQEAAAYLKF116
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1210SQRTLSVQEAAAYLK015
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1210QRTLSVQEAAAYLKF116
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1211SQRTLSVQEAAAYLK015
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1211QRTLSVQEAAAYLKF116
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1212SQRTLSVQEAAAYLK015
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1212QRTLSVQEAAAYLKF116
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1213SQRTLSVQEAAAYLK015
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1213QRTLSVQEAAAYLKF116
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1214SQRTLSVQEAAAYLK015
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1214QRTLSVQEAAAYLKF116
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1215SQRTLSVQEAAAYLK015
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1215QRTLSVQEAAAYLKF116
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1217SQRTLSVQEAAAYLK015
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1217QRTLSVQEAAAYLKF116
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1218SQRTLSVQEAAAYLK015
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1218QRTLSVQEAAAYLKF116
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1219SQRTLSVQEAAAYLK015
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1220SQRTLSVQEAAAYLK015
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1220QRTLSVQEAAAYLKF116
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1221SQRTLSVQEAAAYLK015
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1221QRTLSVQEAAAYLKF116
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1222SQRTLSVQEAAAYLK015
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1222QRTLSVQEAAAYLKF116
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1223SQRTLSVQEAAAYLK015
LEMD3-KCNC2chr1265612399chr12754450971721DRB1-1223QRTLSVQEAAAYLKF116

Top

Fusion breakpoint peptide structures of LEMD3-KCNC2

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
10202VQEAAAYLKFIAFALEMD3KCNC2chr1265612399chr12754450971721

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of LEMD3-KCNC2

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B52:013W3910202VQEAAAYLKFIAFA-4.18549-4.18549
HLA-B44:053DX810202VQEAAAYLKFIAFA-2.46059-2.46059
HLA-A02:016TDR10202VQEAAAYLKFIAFA-4.62563-4.62563

Top

Vaccine Design for the FusionNeoAntigens of LEMD3-KCNC2

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
LEMD3-KCNC2chr1265612399chr12754450971019AAYLKFIAFTATTTAAAATTTATTGCTTTTGCTTCT
LEMD3-KCNC2chr1265612399chr12754450971119AYLKFIAFTTAAAATTTATTGCTTTTGCTTCT
LEMD3-KCNC2chr1265612399chr1275445097516SVQEAAAYLKFCAAGAGGCAGCTGCGTATTTAAAATTTATTGCT
LEMD3-KCNC2chr1265612399chr1275445097716QEAAAYLKFGCAGCTGCGTATTTAAAATTTATTGCT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
LEMD3-KCNC2chr1265612399chr1275445097015SQRTLSVQEAAAYLKAGAACGCTTTCTGTTCAAGAGGCAGCTGCGTATTTAAAATTTATT
LEMD3-KCNC2chr1265612399chr1275445097116QRTLSVQEAAAYLKFACGCTTTCTGTTCAAGAGGCAGCTGCGTATTTAAAATTTATTGCT

Top

Information of the samples that have these potential fusion neoantigens of LEMD3-KCNC2

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
SARCLEMD3-KCNC2chr1265612399ENST00000308330chr1275445097ENST00000298972TCGA-DX-AB2F-01A

Top

Potential target of CAR-T therapy development for LEMD3-KCNC2

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneLEMD3chr12:65612399chr12:75445097ENST00000308330+413475_495565912.0TransmembraneHelical
TgeneKCNC2chr12:65612399chr12:75445097ENST0000029897216230_2500599.0TransmembraneHelical%3B Name%3DSegment S1
TgeneKCNC2chr12:65612399chr12:75445097ENST0000029897216284_3030599.0TransmembraneHelical%3B Name%3DSegment S2
TgeneKCNC2chr12:65612399chr12:75445097ENST0000029897216314_3340599.0TransmembraneHelical%3B Name%3DSegment S3
TgeneKCNC2chr12:65612399chr12:75445097ENST0000029897216346_3680599.0TransmembraneHelical%3B Voltage-sensor%3B Name%3DSegment S4
TgeneKCNC2chr12:65612399chr12:75445097ENST0000029897216382_4020599.0TransmembraneHelical%3B Name%3DSegment S5
TgeneKCNC2chr12:65612399chr12:75445097ENST0000029897216453_4730599.0TransmembraneHelical%3B Name%3DSegment S6
TgeneKCNC2chr12:65612399chr12:75445097ENST0000034166915230_2500630.0TransmembraneHelical%3B Name%3DSegment S1
TgeneKCNC2chr12:65612399chr12:75445097ENST0000034166915284_3030630.0TransmembraneHelical%3B Name%3DSegment S2
TgeneKCNC2chr12:65612399chr12:75445097ENST0000034166915314_3340630.0TransmembraneHelical%3B Name%3DSegment S3
TgeneKCNC2chr12:65612399chr12:75445097ENST0000034166915346_3680630.0TransmembraneHelical%3B Voltage-sensor%3B Name%3DSegment S4
TgeneKCNC2chr12:65612399chr12:75445097ENST0000034166915382_4020630.0TransmembraneHelical%3B Name%3DSegment S5
TgeneKCNC2chr12:65612399chr12:75445097ENST0000034166915453_4730630.0TransmembraneHelical%3B Name%3DSegment S6
TgeneKCNC2chr12:65612399chr12:75445097ENST0000035022815230_2500543.6666666666666TransmembraneHelical%3B Name%3DSegment S1
TgeneKCNC2chr12:65612399chr12:75445097ENST0000035022815284_3030543.6666666666666TransmembraneHelical%3B Name%3DSegment S2
TgeneKCNC2chr12:65612399chr12:75445097ENST0000035022815314_3340543.6666666666666TransmembraneHelical%3B Name%3DSegment S3
TgeneKCNC2chr12:65612399chr12:75445097ENST0000035022815346_3680543.6666666666666TransmembraneHelical%3B Voltage-sensor%3B Name%3DSegment S4
TgeneKCNC2chr12:65612399chr12:75445097ENST0000035022815382_4020543.6666666666666TransmembraneHelical%3B Name%3DSegment S5
TgeneKCNC2chr12:65612399chr12:75445097ENST0000035022815453_4730543.6666666666666TransmembraneHelical%3B Name%3DSegment S6
TgeneKCNC2chr12:65612399chr12:75445097ENST0000039328815230_2500619.0TransmembraneHelical%3B Name%3DSegment S1
TgeneKCNC2chr12:65612399chr12:75445097ENST0000039328815284_3030619.0TransmembraneHelical%3B Name%3DSegment S2
TgeneKCNC2chr12:65612399chr12:75445097ENST0000039328815314_3340619.0TransmembraneHelical%3B Name%3DSegment S3
TgeneKCNC2chr12:65612399chr12:75445097ENST0000039328815346_3680619.0TransmembraneHelical%3B Voltage-sensor%3B Name%3DSegment S4
TgeneKCNC2chr12:65612399chr12:75445097ENST0000039328815382_4020619.0TransmembraneHelical%3B Name%3DSegment S5
TgeneKCNC2chr12:65612399chr12:75445097ENST0000039328815453_4730619.0TransmembraneHelical%3B Name%3DSegment S6
TgeneKCNC2chr12:65612399chr12:75445097ENST0000054001814230_2500584.0TransmembraneHelical%3B Name%3DSegment S1
TgeneKCNC2chr12:65612399chr12:75445097ENST0000054001814284_3030584.0TransmembraneHelical%3B Name%3DSegment S2
TgeneKCNC2chr12:65612399chr12:75445097ENST0000054001814314_3340584.0TransmembraneHelical%3B Name%3DSegment S3
TgeneKCNC2chr12:65612399chr12:75445097ENST0000054001814346_3680584.0TransmembraneHelical%3B Voltage-sensor%3B Name%3DSegment S4
TgeneKCNC2chr12:65612399chr12:75445097ENST0000054001814382_4020584.0TransmembraneHelical%3B Name%3DSegment S5
TgeneKCNC2chr12:65612399chr12:75445097ENST0000054001814453_4730584.0TransmembraneHelical%3B Name%3DSegment S6
TgeneKCNC2chr12:65612399chr12:75445097ENST0000054851305230_2500477.0TransmembraneHelical%3B Name%3DSegment S1
TgeneKCNC2chr12:65612399chr12:75445097ENST0000054851305284_3030477.0TransmembraneHelical%3B Name%3DSegment S2
TgeneKCNC2chr12:65612399chr12:75445097ENST0000054851305314_3340477.0TransmembraneHelical%3B Name%3DSegment S3
TgeneKCNC2chr12:65612399chr12:75445097ENST0000054851305346_3680477.0TransmembraneHelical%3B Voltage-sensor%3B Name%3DSegment S4
TgeneKCNC2chr12:65612399chr12:75445097ENST0000054851305382_4020477.0TransmembraneHelical%3B Name%3DSegment S5
TgeneKCNC2chr12:65612399chr12:75445097ENST0000054851305453_4730477.0TransmembraneHelical%3B Name%3DSegment S6
TgeneKCNC2chr12:65612399chr12:75445097ENST0000054944615230_2500639.0TransmembraneHelical%3B Name%3DSegment S1
TgeneKCNC2chr12:65612399chr12:75445097ENST0000054944615284_3030639.0TransmembraneHelical%3B Name%3DSegment S2
TgeneKCNC2chr12:65612399chr12:75445097ENST0000054944615314_3340639.0TransmembraneHelical%3B Name%3DSegment S3
TgeneKCNC2chr12:65612399chr12:75445097ENST0000054944615346_3680639.0TransmembraneHelical%3B Voltage-sensor%3B Name%3DSegment S4
TgeneKCNC2chr12:65612399chr12:75445097ENST0000054944615382_4020639.0TransmembraneHelical%3B Name%3DSegment S5
TgeneKCNC2chr12:65612399chr12:75445097ENST0000054944615453_4730639.0TransmembraneHelical%3B Name%3DSegment S6
TgeneKCNC2chr12:65612399chr12:75445097ENST0000055043304230_2500630.0TransmembraneHelical%3B Name%3DSegment S1
TgeneKCNC2chr12:65612399chr12:75445097ENST0000055043304284_3030630.0TransmembraneHelical%3B Name%3DSegment S2
TgeneKCNC2chr12:65612399chr12:75445097ENST0000055043304314_3340630.0TransmembraneHelical%3B Name%3DSegment S3
TgeneKCNC2chr12:65612399chr12:75445097ENST0000055043304346_3680630.0TransmembraneHelical%3B Voltage-sensor%3B Name%3DSegment S4
TgeneKCNC2chr12:65612399chr12:75445097ENST0000055043304382_4020630.0TransmembraneHelical%3B Name%3DSegment S5
TgeneKCNC2chr12:65612399chr12:75445097ENST0000055043304453_4730630.0TransmembraneHelical%3B Name%3DSegment S6

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to LEMD3-KCNC2

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to LEMD3-KCNC2

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource